RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares

RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares

CEO Carsten Brunn sold 23,766 shares at $6.82 per share, totaling $162,077, while retaining 323,530 shares.

Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss

Repay posts $0.24 adjusted EPS on flat $77.7M revenue, with GAAP loss of $6.6M highlighting profitability adjustments ahead of tonight's…

CMCT Reports Q4 Loss of $11.20/Share

CMCT reports Q4 loss of $11.20/share, matching prior quarter but widening sharply from $0.37/share year-ago loss.

ACCO Brands adjusted earnings per share of $0.38 for Q4 2025

ACCO Brands posts Q4 adjusted EPS of $0.38, flat sequentially but down 2.6% year-over-year, as revenue declines 4.3% to $428.8…

BREAKING: KFY Reports Q3 Earnings

Korn Ferry posts Q3 adjusted EPS of $1.28 on revenue of $725M.

Vicor (VICR) reported Q4 2025 diluted EPS of $1.01

Vicor's Q4 EPS of $1.10 crushed the $0.48 estimate, yet shares dropped 10.6% as revenue surged 310% sequentially to $452.7M.

FN Shares Plunge 10% Despite Earnings Beat as Q1 Revenue Guidance Signals 17.9% Sequential Drop

FN's Q4 EPS of $3.36 beat estimates by 3.4%, but shares plunged 10% on weak Q1 guidance calling for a…

BREAKING: FCEL Reports Wider Q1 FY26 Loss Than Expected

FuelCell Energy reports Q1 loss of $0.91/share, wider than the $0.68 estimate.

Cipher Digital (CIFR) Stock Plunges 10% as Q4 Adjusted Loss of $1.92/Share Misses Estimate by 1,377%

Cipher Digital posts $1.92 loss vs $0.13 estimate as Q4 net loss hits $822M; stock drops 10% on profitability collapse.

ARS Pharmaceuticals (SPRY) Posts Q4 Loss of $0.42/Share as Revenue Jumps 332% YoY to $28.1M

ARS Pharmaceuticals reports Q4 loss of $0.42/share as revenue surges 332% YoY to $28.1M despite sequential decline from Q3 peak.